跳至主要内容
临床试验/JPRN-UMIN000020748
JPRN-UMIN000020748招募中2 期

Multi-center clinical trial for Japanese children with bilateral nephroblastoma(RTBL14) - Clinical trial for bilateral nephroblastoma

Japan Children's Cancer Group(JCCG) (Japan Wilms Tumor Study Group, JWiTS)0 个研究点目标入组 17 人开始时间: 2016年1月26日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
17

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 18years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Cases with one of the following factors 1)Recurrent disease 2)Active double cancer, synchronous or remission less than 5 years 3)Performance Status (ECOG/Zubrod Score) is 4 (Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair) 4)Severe organ failure (hematologic, liver, kidney, heart) White blood cells < 2000/mm3 Platelets <100,000/mm3 Serum bilirubin > 2.5 x normal limit Serum ALT > 2.5 x normal limit Serum total bile acid > 2.5 x normal limit Serum creatinine > 2.5 x normal limit 5) Patient unable to undergo chemotherapy due to other disease, or the attending doctor considers inappropriate to entry this study. 6)The patient has a psychological disorder so that unable for entry. 7)Patient unable to tolerate the chemotherapy for any reason

研究者

发起方
Japan Children&#39;s Cancer Group(JCCG) (Japan Wilms Tumor Study Group, JWiTS)

相似试验